Brand: ProteoGenix

Vesencumab Biosimilar – Anti-Neuropilin-1, NRP1, VEGF165R extracellular domain mAb – Research Grade

PX-TA1266-100UG
Quality Chart

Clonality:: Monoclonal Antibody
Isotype:: IgG1, kappa

$238.00

100ug + 238 loyalty points

Size Size

100ug $238.00
1MG $952.00

First Name This field is required. Last Name This field is required. Email This field is required. Company This field is required. Country This field is required. State This field is required.

In Stock
Wide range of unique reagents
Fast worldwide delivery

Vesencumab Biosimilar - Anti-Neuropilin-1, NRP1, VEGF165R extracellular domain mAb - Research Grade

Product name	Vesencumab Biosimilar - Anti-Neuropilin-1, NRP1, VEGF165R extracellular domain mAb - Research Grade
Source	CAS 1205533-60-3
Species	Homo sapiens
Purity	>85%
Buffer	PBS buffer PH7.5
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	store at -80°C
Brand	ProteoGenix
Applications	ELISA,WB
Aliases /Synonyms	Vesencumab,MNRP1685A,Neuropilin-1, NRP1, VEGF165R extracellular domain ,anti-Neuropilin-1, NRP1, VEGF165R extracellular domain
Reference	PX-TA1266
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	IgG1-kappa
Clonality	Monoclonal Antibody

Product name	Vesencumab Biosimilar - Anti-Neuropilin-1, NRP1, VEGF165R extracellular domain mAb - Research Grade
Source	CAS 1205533-60-3
Species	Homo sapiens
Purity	>85%
Buffer	PBS buffer PH7.5
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	store at -80°C
Brand	ProteoGenix
Applications	ELISA,WB,,,
Aliases /Synonyms	Vesencumab,MNRP1685A,Neuropilin-1, NRP1, VEGF165R extracellular domain ,anti-Neuropilin-1, NRP1, VEGF165R extracellular domain
Reference	PX-TA1266
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	IgG1-kappa
Clonality	Monoclonal Antibody

General information on Anti-Neuropilin-1/NRP1/VEGF165R extracellular domain [Homo sapiens] (Vesencumab) Monoclonal Antibody

Vesencumab is investigated for the treatment of Locally Advanced or Metastatic Solid Tumors.

There are no reviews yet.

Be the first to review “Vesencumab Biosimilar – Anti-Neuropilin-1, NRP1, VEGF165R extracellular domain mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Your rating *

In which application did you use the antibody? *

Did it work in your application? * Yes No

Your review *

Name *

Email *

Vesencumab Biosimilar – Anti-Neuropilin-1, NRP1, VEGF165R extracellular domain mAb – Research Grade

Vesencumab Biosimilar - Anti-Neuropilin-1, NRP1, VEGF165R extracellular domain mAb - Research Grade

General information on Anti-Neuropilin-1/NRP1/VEGF165R extracellular domain [Homo sapiens] (Vesencumab) Monoclonal Antibody

Related products

Neuropilin-1 recombinant protein

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

Recently viewed products

Can’t find what you need?

Cart (0 Items)

Vesencumab Biosimilar – Anti-Neuropilin-1, NRP1, VEGF165R extracellular domain mAb – Research Grade

Specifications Vesencumab Biosimilar - Anti-Neuropilin-1, NRP1, VEGF165R extracellular domain mAb - Research Grade

Description

General information on Anti-Neuropilin-1/NRP1/VEGF165R extracellular domain [Homo sapiens] (Vesencumab) Monoclonal Antibody

Documents

Reviews

Related products

Neuropilin-1 recombinant protein

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

Recently viewed products

Can’t find what you need?

Cart (0 Items)

Vesencumab Biosimilar - Anti-Neuropilin-1, NRP1, VEGF165R extracellular domain mAb - Research Grade